Equities

Alliance Pharma PLC

Alliance Pharma PLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (GBX)44.50
  • Today's Change0.20 / 0.45%
  • Shares traded2.01m
  • 1 Year change+16.34%
  • Beta0.8144
Data delayed at least 20 minutes, as of Nov 21 2024 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Thursday, Alliance Pharma PLC (APH:LSE) closed at 44.50, -9.55% below its 52-week high of 49.20, set on Nov 11, 2024.
52-week range
Today
24.55May 08 202449.20Nov 11 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open44.40
High45.20
Low44.20
Bid44.25
Offer45.00
Previous close44.30
Average volume885.37k
Shares outstanding540.57m
Free float475.98m
P/E (TTM)--
Market cap239.47m GBP
EPS (TTM)-0.0622
GBP
Annual div (ADY)--
Annual div yield (ADY)--
Div ex-dateJun 22 2023
Div pay-dateJul 18 2023
Data delayed at least 20 minutes, as of Nov 21 2024 16:35 GMT.
More ▼

Investors Chronicle View

The last IC recommendation on Alliance Pharma PLC shares was Hold at 41.00 on 30 Sep 2024Read the full article
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.